Mutual of America Capital Management LLC Purchases 650 Shares of Align Technology, Inc. (NASDAQ:ALGN)

Mutual of America Capital Management LLC lifted its position in Align Technology, Inc. (NASDAQ:ALGNGet Rating) by 6.1% in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 11,221 shares of the medical equipment provider’s stock after buying an additional 650 shares during the quarter. Mutual of America Capital Management LLC’s holdings in Align Technology were worth $2,656,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also made changes to their positions in ALGN. BlackRock Inc. boosted its position in Align Technology by 11.0% during the first quarter. BlackRock Inc. now owns 6,373,398 shares of the medical equipment provider’s stock worth $2,778,802,000 after purchasing an additional 630,238 shares during the period. Brown Advisory Inc. boosted its position in Align Technology by 3,884.2% during the first quarter. Brown Advisory Inc. now owns 474,245 shares of the medical equipment provider’s stock worth $206,771,000 after purchasing an additional 462,342 shares during the period. Keybank National Association OH boosted its position in Align Technology by 56,573.8% during the second quarter. Keybank National Association OH now owns 426,754 shares of the medical equipment provider’s stock worth $101,000,000 after purchasing an additional 426,001 shares during the period. Wellington Management Group LLP boosted its position in Align Technology by 23.0% during the first quarter. Wellington Management Group LLP now owns 1,798,137 shares of the medical equipment provider’s stock worth $783,989,000 after purchasing an additional 336,781 shares during the period. Finally, BNP Paribas Arbitrage SA boosted its position in Align Technology by 481.8% during the first quarter. BNP Paribas Arbitrage SA now owns 188,512 shares of the medical equipment provider’s stock worth $82,191,000 after purchasing an additional 156,110 shares during the period. 86.50% of the stock is owned by institutional investors.

Insiders Place Their Bets

In other news, CEO Joseph M. Hogan acquired 10,600 shares of the stock in a transaction dated Wednesday, November 2nd. The stock was bought at an average price of $188.58 per share, with a total value of $1,998,948.00. Following the completion of the purchase, the chief executive officer now directly owns 185,401 shares of the company’s stock, valued at approximately $34,962,920.58. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. In other news, Director Warren S. Thaler acquired 1,050 shares of the stock in a transaction dated Wednesday, November 2nd. The stock was bought at an average price of $191.21 per share, with a total value of $200,770.50. Following the completion of the purchase, the director now directly owns 30,666 shares of the company’s stock, valued at approximately $5,863,645.86. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, CEO Joseph M. Hogan acquired 10,600 shares of the stock in a transaction dated Wednesday, November 2nd. The stock was purchased at an average cost of $188.58 per share, with a total value of $1,998,948.00. Following the purchase, the chief executive officer now directly owns 185,401 shares of the company’s stock, valued at $34,962,920.58. The disclosure for this purchase can be found here. Insiders own 0.64% of the company’s stock.

Align Technology Trading Down 0.1 %

Shares of NASDAQ ALGN opened at $191.39 on Wednesday. The company has a market cap of $14.95 billion, a price-to-earnings ratio of 29.58, a PEG ratio of 27.09 and a beta of 1.68. Align Technology, Inc. has a 12 month low of $172.05 and a 12 month high of $688.60. The stock has a 50-day moving average price of $208.52 and a two-hundred day moving average price of $243.70.

Align Technology (NASDAQ:ALGNGet Rating) last issued its earnings results on Wednesday, October 26th. The medical equipment provider reported $1.36 EPS for the quarter, missing the consensus estimate of $1.94 by ($0.58). The business had revenue of $890.35 million for the quarter, compared to analyst estimates of $973.00 million. Align Technology had a return on equity of 14.39% and a net margin of 13.22%. The firm’s revenue was down 12.4% compared to the same quarter last year. During the same period in the previous year, the firm posted $2.28 EPS. On average, sell-side analysts predict that Align Technology, Inc. will post 5.81 earnings per share for the current year.

Analyst Ratings Changes

A number of brokerages have recently issued reports on ALGN. Piper Sandler reduced their target price on shares of Align Technology from $300.00 to $230.00 in a research report on Thursday, October 27th. Stephens reduced their target price on shares of Align Technology from $500.00 to $375.00 and set an “overweight” rating for the company in a research report on Thursday, July 28th. Robert W. Baird reduced their target price on shares of Align Technology from $310.00 to $260.00 in a research report on Thursday, October 27th. The Goldman Sachs Group reduced their target price on shares of Align Technology from $250.00 to $165.00 and set a “sell” rating for the company in a research report on Thursday, October 27th. Finally, StockNews.com began coverage on shares of Align Technology in a research report on Wednesday, October 12th. They issued a “hold” rating for the company. One analyst has rated the stock with a sell rating, one has assigned a hold rating and seven have issued a buy rating to the company’s stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $298.00.

About Align Technology

(Get Rating)

Align Technology, Inc, a medical device company, designs, manufactures, and markets Invisalign clear aligners and iTero intraoral scanners and services for orthodontists and general practitioner dentists, and restorative and aesthetic dentistry. It operates in two segments, Clear Aligner; and Scanners and Services.

Recommended Stories

Institutional Ownership by Quarter for Align Technology (NASDAQ:ALGN)

Receive News & Ratings for Align Technology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Align Technology and related companies with MarketBeat.com's FREE daily email newsletter.